TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
GSK

GlaxoSmithKline PLC

Healthcare · Drug Manufacturers - General

50.50$ +0.3% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Cash Flow

GlaxoSmithKline PLC (GSK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 2,536 million GBP. Tick rows to compare them in a chart.

All figures in millions of GBP.

Tick rows to compare them in a chart (up to 4)

Cash Flow GSK
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
2,212 3,619 1,191 1,113 2,154 2,329 1,145 2,096 3,028 2,036 1,141 2,536 8,740
579 1,461 696 639 951 412 823 1,159 995 783 463 224 2,465
307 307
-89
164 1,821 -394 -618 -740 3,759 -788 -1,031 -1,067 1,384 -1,082 -12 -777
497 587 314 442 842 1,135 448 633 428 560 443 329 1,761
-491 292 -255 770 -731 -1,119 -1,144 -625 -2,150 -2,363 -1,466 -881 -6,860
567 674 720 652 612 612 612 656 905 628 643 729 2,906
9.0 -49 0.0 20 20 -247 -561 -448 -1,362 -326 -308 -2,445
-1,098 -548 244 1,918 -874 -86 548 1,182 -632 1,012
-1,762 -4,063 -1,254 -1,584 -1,240 -842 858 -2,372 -1,707 808 272 -1,904 -2,530
-18 -135 -218 291 149 375 848 -927 -495 98 -51 -313 -761
1,715 3,031 876 671 1,312 1,194 697 1,463 2,599 1,476 698 2,207 6,980

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?